TARS - Tarsus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

TARS is currently covered by 7 analysts with an average price target of $103.86. This is a potential upside of $30.85 (42.25%) from yesterday's end of day stock price of $73.01.

Tarsus Pharmaceuticals's activity chart (see below) currently has 82 price targets and 66 ratings on display. The stock rating distribution of TARS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 79.67% of the time, taking 417.6 days on average.

Highest price target for TARS is $116, Lowest price target is $97, average price target is $103.86.

Most recent stock forecast was given by EDDIE HICKMAN from GUGGENHEIM on 05-Nov-2026. First documented stock forecast 10-Nov-2020.

Currently out of the existing stock ratings of TARS, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Jun-2023

$97

$23.99 (32.86%)

$90

17 days ago
(05-Nov-2026)

7/8 (87.5%)

$29.48 (43.66%)

375

Buy Since 27-May-2025

$106

$32.99 (45.19%)

$88

18 days ago
(04-Nov-2026)

4/5 (80%)

$36.93 (53.47%)

160

Buy Since 24-Sep-2026

$116

$42.99 (58.88%)

$51

1 months 29 days ago
(24-Sep-2026)

3/4 (75%)

$40.04 (52.71%)

111

Buy Since 10-Nov-2020

$105

$31.99 (43.82%)

$58

2 months 14 days ago
(08-Sep-2026)

4/5 (80%)

$17.78 (20.39%)

418

Buy Since 25-Mar-2026

$98

$24.99 (34.23%)

$100

3 months 22 days ago
(31-Jul-2026)

0/4 (0%)

$38.96 (65.99%)

Show more analysts

Please expand the browser size to see the chart

What is TARS (Tarsus Pharmaceuticals) average time for price targets to be met?

On average it took 418 days for the stock forecasts to be reached, with an average price target met ratio of 79.67%.

Which analyst most recently updated their price target on TARS (Tarsus Pharmaceuticals)?

Eddie Hickman

Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals)?

Eddie Hickman works at GUGGENHEIM and has 16 price targets and 8 ratings on TARS

Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals)?

Andrea Tan with the highest potential upside of $42.99

Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals)?

Jason Gerberry with the lowest potential downside of -$10.01
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?